Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Empowering Kazakh Students: VEON’s Beeline Kazakhstan introduces AI-based Tutor powered by KazLLM
-
Incannex Healthcare Inc. Expands IHL-42X Clinical Advisory Board with Appointments of Four Industry and Academic Leaders to Advance Obstructive Sleep Apnea (OSA) Program
-
Sanuwave Health Appoints Industry Veteran Dustin Libby as Executive Vice President of Commercial Operations
-
Rekor Systems Selected for Statewide Texas DOT Contract to Deploy Rekor Command® Platform
-
Empowering Kazakh Students: VEON’s Beeline Kazakhstan introduces AI-based Tutor powered by KazLLM
-
XPOLAR X Series: The Innovative Device Redefining Sports Recovery
-
NIO Inc. Reports Unaudited First Quarter 2025 Financial Results
-
Teva Announces Early Tender Results of its Debt Tender Offer, Increase to Tender Pool Caps and Total Maximum Amount and Election of Early Settlement
-
Bravo | HGTV | Food Network | Discovery | FX | Magnolia Network | ID: Fan-Favourite Shows Lead Powerhouse Specialty Portfolio from Rogers Sports & Media
-
Draganfly Announces Delivery of Flex FPV Systems to Major U.S. Prime Defense Contractor
-
Emerging Markets Report: Shedding Some Light
-
Gilat Signs a $40 Million Contract for Virtualized SkyEdge IV Platform
-
Kraig Biocraft Laboratories Issues a Letter to Shareholders on Recent Advancements and Potential Recombinant Spider Silk Deliveries in 2025
-
Cartesian Therapeutics Announces New Employment Inducement Grants
-
Dimensional Fund Advisors Ltd. : Form 8.3 - AVIVA PLC - Ordinary Shares
-
Gold Candle Files Technical Report for Kerr-Addison and Geminid Deposits
-
Vanqua Bio to Present at Upcoming Scientific Conferences
-
Supporting Regional Integration with Payment Services: UnionPay Attends the First ASEAN-GCC-China Economic Forum
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Fury Announces 2025 Exploration Plans at Committee Bay
-
Conavi Medical Announces New Grant of Stock Options
-
Guardian Capital LP Launches New GuardBonds™ Funds
-
A New Era for the Canada-U.S. Relationship
-
Matador Technologies Inc. Announces Listing on the Frankfurt Stock Exchange
-
Proven Hits Return to Citytv & Citytv+; The Price is Right Tonight with Host Howie Mandel, Coming Spring 2026
-
Flock Safety and Homegrown Launch the “Thriving Cities Fund” to Empower Local Entrepreneurs and Foster Safer, More Prosperous Communities
-
VEON and Engro Corporation Complete Pioneering Infrastructure Partnership in Pakistan
-
BioStem Technologies Provides Update on the Company’s Form 10 Submission and SEC Review Process
-
Halcones Precious Metals Provides Update on Polaris Gold Project, Antofagasta Region Chile
-
Next Hydrogen announces transition of its COO to a consulting arrangement
-
BeyondSpring Presents Efficacy/Safety Data from a Phase 2 Study of Pembrolizumab plus Plinabulin/Docetaxel in Metastatic NSCLC after Progressing on First-Line Immune Checkpoint Inhibitors at 2025 ASCO
-
Sultran Ltd. Celebrates 50 Years of Industry Leadership and Innovation
-
Greenbacker delivers first quarter results
-
Bio-Path Holdings Provides Clinical and Operational Update
-
Xtract One Announces Updates on One Gateway Launch
-
New Analysis of Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) Published in Muscle and Nerve
-
I-Mab to Participate in the H.C. Wainwright “HCW@Home” Series
-
ValOre Highlights Strategic Synergies and Near-Term Exploration Plans for the Combined Pedra Branca Gold and PGM Projects, Ceara State, Brazil
-
QuantaSing to Report Third Fiscal Quarter Financial Results on June 6, 2025
-
Swvl Signs Its First SaaS Contract in the UK, Marking Entry into the European Market
-
Brookfield Announces Reset Dividend Rate on Its Series 42 Preference Shares
-
Traws Pharma Announces Publication of Compelling Efficacy data in RDEB SCC Patients Treated with Legacy Oncology Drug Rigosertib
-
Beam Therapeutics Announces U.S. FDA Orphan Drug Designation Granted to BEAM-101 for the Treatment of Sickle Cell Disease
-
FactSet Announces CEO Succession Plan
-
Monopar Therapeutics Announces Inclusion in the Russell 3000® and Russell 2000® Indexes
-
Chicago Atlantic BDC, Inc. Announces 2025 Annual Meeting of Stockholders’ Date
-
NIRI Twin Cities Chapter Elects 2025-2026 Board of Directors
-
Entrada Therapeutics Appoints Maha Radhakrishnan, M.D., to its Board of Directors
-
Akero Therapeutics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
-
Transpire Bio Enters into Exclusive License Agreement with Suzhou Intragrand Pharma for Investigational PDE4 Inhibitor
